Patrick Deegan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Risk Assessment

Replacement Therapy

Cross Sectional

Top Venues

Journal of clinical medicine

Orphanet journal of rare diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Deborah Elstein, Nadia Belmatoug, Bruno Bembi, Patrick Deegan, Diego Fernandez-Sasso, Pilar Giraldo, Ozlem Goker-Alpan, Derralynn Hughes, Heather Lau, Elena Lukina, Shoshana Revel-Vilk, Ida Vanessa D Schwartz, Majdolen Istaiti, Jaco Botha, Noga Gadir, Jörn Schenk, Ari Zimran, null null
Twelve Years of the Gaucher Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global Patient Registry. Journal of clinical medicine 13 (12) (2024)
Deborah Elstein, Nadia Belmatoug, Bruno Bembi, Patrick Deegan, Diego Fernandez-Sasso, Pilar Giraldo, Ozlem Goker-Alpan, Derralynn Hughes, Heather Lau, Elena Lukina, Shoshana Revel-Vilk, Ida Vanessa D Schwartz, Majdolen Istaiti, Jaco Botha, Noga Gadir, Jörn Schenk, Ari Zimran, null null
Twelve Years of the Gaucher Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global Patient Registry. Journal of clinical medicine 13 (12) (2024)
Patrick Deegan, Heather Lau, Deborah Elstein, Diego Fernandez-Sasso, Pilar Giraldo, Derralynn Hughes, Ari Zimran, Majdolen Istaiti, Noga Gadir, Jaco Botha, Shoshana Revel-Vilk, null null
Long-Term Treatment of Gaucher Disease with Velaglucerase Alfa in ERT-Naïve Patients from the Gaucher Outcome Survey (GOS) Registry. Journal of clinical medicine 13 (10) (2024)
Patrick Deegan, Heather Lau, Deborah Elstein, Diego Fernandez-Sasso, Pilar Giraldo, Derralynn Hughes, Ari Zimran, Majdolen Istaiti, Noga Gadir, Jaco Botha, Shoshana Revel-Vilk, null null
Long-Term Treatment of Gaucher Disease with Velaglucerase Alfa in ERT-Naïve Patients from the Gaucher Outcome Survey (GOS) Registry. Journal of clinical medicine 13 (10) (2024)
Derralynn A Hughes, Patrick Deegan, Pilar Giraldo, Ozlem Goker-Alpan, Heather Lau, Elena Lukina, Shoshana Revel-Vilk, Maurizio Scarpa, Jaco Botha, Noga Gadir, Ari Zimran, null null
Reply to Mistry et al. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on "Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11 , 5158". Journal of clinical medicine 12 (12) (2023)
Derralynn A Hughes, Patrick Deegan, Pilar Giraldo, Ozlem Goker-Alpan, Heather Lau, Elena Lukina, Shoshana Revel-Vilk, Maurizio Scarpa, Jaco Botha, Noga Gadir, Ari Zimran, null null
Reply to Mistry et al. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on "Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11 , 5158". Journal of clinical medicine 12 (12) (2023)
Simona D'Amore, Hiroshige Sano, Daniel David George Chappell, Davide Chiarugi, Olivia Baker, Kathleen Page, Uma Ramaswami, Fjola Johannesdottir, Timothy M Cox, Patrick Deegan, Kenneth E S Poole, null null, null null
Radiographic Cortical Thickness Index Predicts Fragility Fracture in Gaucher Disease. Radiology (2022)
Simona D'Amore, Hiroshige Sano, Daniel David George Chappell, Davide Chiarugi, Olivia Baker, Kathleen Page, Uma Ramaswami, Fjola Johannesdottir, Timothy M Cox, Patrick Deegan, Kenneth E S Poole, null null, null null
Radiographic Cortical Thickness Index Predicts Fragility Fracture in Gaucher Disease. Radiology (2022)
Patrick Deegan, Aneal Khan, José Simon Camelo, Julie L Batista, Neal Weinreb
The International Collaborative Gaucher Group GRAF (Gaucher Risk Assessment for Fracture) score: a composite risk score for assessing adult fracture risk in imiglucerase-treated Gaucher disease type 1 patients. Orphanet journal of rare diseases 16 (1) (2021)